cs 834 has been researched along with cilastatin in 2 studies
| Studies (cs 834) | Trials (cs 834) | Recent Studies (post-2010) (cs 834) | Studies (cilastatin) | Trials (cilastatin) | Recent Studies (post-2010) (cilastatin) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 999 | 270 | 137 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, R; Hisaoka, M; Kawamoto, I; Miyauchi, M; Yasuda, H | 1 |
| Domon, H; Furuya, N; Ishii, K; Matsumoto, T; Miyazaki, S; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
2 other study(ies) available for cs 834 and cilastatin
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834.
Topics: Administration, Oral; Animals; Carbapenems; Cilastatin; Dogs; Drug Interactions; Gram-Positive Bacteria; Injections, Intravenous; Mice; Microbial Sensitivity Tests; Protease Inhibitors; Structure-Activity Relationship | 1997 |
In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.
Topics: Animals; Carbapenems; Cilastatin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Prodrugs; Protease Inhibitors; Sepsis | 1998 |